IA

Ilaxiben Atulkumar Surati

Active Director Director DIN 11978100
DIN 11978100 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ilaxiben Atulkumar Surati

Ilaxiben Atulkumar Surati is a Director at Valorix Biosciences Private Limited (since 2026).

DIN 11978100
Primary Designation Director
First Appointment 29 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Valorix Biosciences Private Limited U21004GJ2026PTC184466
Director29 Sep 20262026Active

Board colleagues of Ilaxiben Atulkumar Surati

NameDINCompanyDesignation
Parth Atulkumar Surati11699491Valorix Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Valorix Biosciences Private Limited
Premium access

Shareholding and investment profile for Ilaxiben Atulkumar Surati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ilaxiben Atulkumar Surati

Ilaxiben Atulkumar Surati currently holds 1 directorship: Valorix Biosciences Private Limited (Director, since 29 Sep 2026).

Ilaxiben Atulkumar Surati was first appointed on 29 Sep 2026 as Director at Valorix Biosciences Private Limited.

The current boards of Ilaxiben Atulkumar Surati's companies include Parth Atulkumar Surati (Valorix Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available